Market Cap (In USD)
13.76 Million
Revenue (In USD)
163.22 Thousand
Net Income (In USD)
-1.42 Million
Avg. Volume
1250.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.12476-0.2303
- PE
- -
- EPS
- -
- Beta Value
- -0.458
- ISIN
- CA09073K1084
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Rashid Ahmed Maula Bux B.Sc., MBA
- Employee Count
- -
- Website
- https://www.biomarkdiagnostics.com
- Ipo Date
- 2015-03-23
- Details
- BioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It has a collaborative research agreement with the Icahn School of Medicine for clinical studies related to early lung cancer diagnosis. The company was incorporated in 2014 and is headquartered in Richmond, Canada. BioMark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.
More Stocks
-
WCRS
-
6098
-
4208UBE Corporation
4208
-
TNT-UN
-
300423
-
FTG
-
KGL
-
000958